EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

TNFAIP3 interacting protein 2 relieves lipopolysaccharide (LPS)‐induced inflammatory injury in endometritis by inhibiting NF‐kappaB activation

Xinxin Qian iD, Yan Wang, Xingmei Li, Yuewen Li, Liping Li

Immunity, Inflammation and Disease · 2023

DOI: 10.1002/iid3.970 ↗

At a glance

Journal article in Immunity, Inflammation and Disease, 2023. Written by Xinxin Qian and 4 co-authors. Institution: Department of Gynecology, The Third Affiliated Hospital of Qiqihar Medical College, Qiqihar, China. Major MEDLINE topics: NF-kappa B, Endometritis. Cited 9 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Endometritis seriously affects the health of women, and it is important to identify new targets for its treatment.

Objective

This study aimed to explore the role of TNFAIP3 interacting protein 2 (TNIP2) in endometritis through human endometrial epithelial cells (hEECs) stimulated by lipopolysaccharide (LPS). Methods hEECs were induced with LPS to build a cellular model of endometritis. Cell growth and apoptosis were detected by cell counting kit‐8 and flow cytometry. The TNIP2 mRNA and protein levels were measured using reverse transcription quantitative polymerase chain reaction (RT‐qPCR) and western blot analysis, respectively. The caspase3 activity was calculated using a Caspase3 activity kit. Interleukin (IL)−1β, IL‐6, and tumor necrosis factor‐alpha (TNF‐α) levels were determined by enzyme‐linked‐immunosorbent‐assay. The reactive oxygen species (ROS), lactate dehydrogenase (LDH), catalase (CAT), and superoxide dismutase (SOD) levels were determined using the corresponding kits. Nuclear factor‐kappaB (NF‐κB) pathway was determined by western blot assay.

Results

TNIP2 was downregulated in the LPS‐induced endometritis cell model. Cell viability was reduced, apoptosis was enhanced, and IL‐6, IL‐1β, and TNF‐α levels increased in LPS‐induced hEECs. Additionally, LDH activity and ROS concentration were upregulated, whereas CAT and SOD activities were downregulated in LPS‐induced hEECs. These results were reversed by TNIP2 overexpression. Moreover, the results hinted that NF‐κB was involved in the effects of TNIP2 on the LPS‐induced endometritis cell model.

Conclusion

TNIP2 alleviated endometritis by inhibiting the NF‐κB pathway, suggesting a potential therapeutic target for endometritis.

Subjects

MeSH terms (MEDLINE)

NF-kappa BEndometritisHumansFemaleLipopolysaccharidesSignal TransductionTumor Necrosis Factor-alphaInterleukin-6Reactive Oxygen SpeciesSuperoxide DismutaseTumor Necrosis Factor alpha-Induced Protein 3Adaptor Proteins, Signal Transducing

Author keywords

NF-κBTNIP2endometritisinflammationoxidative stress

Substances

NF-kappa BLipopolysaccharidesTumor Necrosis Factor-alphaInterleukin-6Reactive Oxygen SpeciesSuperoxide DismutaseTNFAIP3 protein, humanTumor Necrosis Factor alpha-Induced Protein 3TNIP2 protein, humanAdaptor Proteins, Signal Transducing

Authors and institutions

  • Department of Gynecology, The Third Affiliated Hospital of Qiqihar Medical College, Qiqihar, China.

ORCID profiles: Xinxin Qian

Cite

APA

Qian, X., Wang, Y., Li, X., Li, Y., & Li, L. (2023). TNFAIP3 interacting protein 2 relieves lipopolysaccharide (LPS)‐induced inflammatory injury in endometritis by inhibiting NF‐kappaB activation. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.970

Vancouver

Qian X, Wang Y, Li X, Li Y, Li L. TNFAIP3 interacting protein 2 relieves lipopolysaccharide (LPS)‐induced inflammatory injury in endometritis by inhibiting NF‐kappaB activation. Immunity, Inflammation and Disease. 2023. doi:10.1002/iid3.970

BibTeX
@article{Qian2023,
  author = {Qian, Xinxin and Wang, Yan and Li, Xingmei and Li, Yuewen and Li, Liping},
  title = {TNFAIP3 interacting protein 2 relieves lipopolysaccharide (LPS)‐induced inflammatory injury in endometritis by inhibiting NF‐kappaB activation},
  journal = {Immunity, Inflammation and Disease},
  year = {2023},
  doi = {10.1002/iid3.970}
}
Start for free →